Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Lindsay Gamble (NPI 1740790179)

Field	Value
Entity Type	Individual
Organization	Lindsay Gamble
Address	40 Okatie Center Blvd S
City	Okatie
State	SC
ZIP	29909
Taxonomy	Family Nurse Practitioner
NPI Enumerated	October 12, 2017

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

LINDSAY GAMBLE is a Family Nurse Practitioner based in OKATIE, SC with an NPI enumerated on 2017-10-12 (~9 years ago), indicating roughly nine years of Medicare enrollment and activity under this billing identity. This tenure supports a sustained Medicare practice footprint rather than a newly established billing pattern.

This provider’s billing is effectively single-payer: total Medicare revenue is $3.7M and there is no Medicaid billing on file. The absence of Medicaid activity means any payer/contracting analysis should treat this entity as Medicare-focused for network and utilization implications.

Revenue is highly concentrated in a small set of biologic drug codes: the top three Medicare codes (J3245, J0897, J3380) account for 54.7% of Medicare revenue. Specifically, J3245 drives 22.6% of Medicare revenue, J0897 drives 17.3%, and J3380 drives 14.8%, together forming the majority of the practice’s Medicare receipts.

The mix of top codes and associated administration codes points to an infusion/biologic therapy practice model: J3245 (tildrakizumab), J0897 (denosumab), and J3380 (vedolizumab) are specialty biologic injections/infusions used to treat conditions such as psoriasis, bone disease, and inflammatory bowel disease, and the presence of administration codes (e.g., 96365, 96413, 96372) indicates in-office or clinic-based infusion capability. Though many administration codes contribute small individual revenue shares, their presence supports a workflow that includes on-site drug administration rather than only prescription fills.

Competitive standing varies by code: J0897 ranks #66 of 10057 providers nationally (99th percentile; extreme outlier), indicating exceptionally high national volume for denosumab relative to peers. J3380 ranks #26 of 620 (96th percentile; notably above typical national volume) showing above-typical vedolizumab activity, while J3245 ranks #32 of 225 (86th percentile; typical, unremarkable volume) and sits at a more modest national position.

Certain administration and injection codes show extreme or unusually high utilization compared with peers: 96372 ranks #230 of 58224 providers nationally (100th percentile; extreme outlier), which suggests very high throughput of basic injection encounters in this practice. By contrast, many other biologic and infusion codes (for example J3111, J1306, J1745) are described as typical or unremarkable in volume, indicating the practice concentrates its exceptional volume in a subset of therapies.

From a business-implication standpoint, the heavy reliance on a handful of high-cost biologic codes means payer coverage, formulary changes, or reimbursement shifts for J0897 and J3380 could materially affect the provider’s Medicare revenue profile. Conversely, the clinic’s demonstrated capacity to administer infusions in-office may be a negotiation point for payers or a differentiator when considered for specialty infusion networks.

Operational and referral implications: the combination of high-volume biologic billing and in-office administration codes suggests this provider could function as a destination for ongoing biologic therapy rather than episodic procedures. For analysts evaluating network adequacy or competitive positioning in SC, this provider should be considered a specialized Medicare infusion/biologic administrator with little to no Medicaid footprint.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	7,500	$110	$825K
J0897	Injection, denosumab, 1 mg	35,100	$20	$631.8K
J3380	Injection, vedolizumab, intravenous, 1 mg	31,800	$20	$540.6K
J2182	Injection, mepolizumab, 1 mg	15,400	$20	$354.2K
J2357	Injection, omalizumab, 5 mg	8,940	$30	$268.2K
J3111	Injection, romosozumab-aqqg, 1 mg	30,870	$10	$247K
J1306	Injection, inclisiran, 1 mg	21,870	$10	$196.8K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	5,130	$30	$174.3K
J9312	Injection, rituximab, 10 mg	2,680	$60	$166.2K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,110	$30	$158.9K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Carolina Distribution

Lindsay Gamble — 7 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Carolina

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	1	20	3,800	$110	$435.3K
J0129	33	40	9,640	$30	$424.2K
J3380	1	20	11,400	$20	$231K
J9312	7	20	2,340	$60	$193.7K
J2357	7	30	4,360	$30	$183.8K
J2182	2	10	5,050	$20	$146.9K
J3111	2	40	12,390	$10	$129.4K
J1745	8	50	3,250	$30	$107K
J1306	1	20	8,800	$10	$95.1K
J0897	2	250	2,400	$20	$91.2K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Lindsay Gamble, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Palmetto Infusion Services LLC	SC	Infusion Therapy Clinic/Center	$0	$93.6M
Beaufort County Memorial Hospital	SC	General Acute Care Hospital	$0	$35.9M
Riverside Radiology And Interventional Associates Inc	OH	Diagnostic Radiology Physician	$0	$30.3M
Somc Medical Care Foundation, Inc.	OH	Family Medicine Physician	$0	$25.3M
Musc Community Physicians	SC	Internal Medicine Physician	$0	$16.7M
Kristi Hunter	GA	General Practice Physician	$6.4M	$0
Rachel Tedesco	NC	Nurse Practitioner	$5.7M	$0
Musc Community Physicians	SC	Family Medicine Physician	$0	$5.6M
Stephen Parks	SC	Family Medicine Physician	$3.9M	$0
Charles Butler	SC	Internal Medicine Physician	$3.8M	$0

Nearby Providers

Other providers in the same ZIP code as Lindsay Gamble, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Palmetto Pediatrics Of The Lowcountry	SC	Pediatrics Physician	$0	$7.8M
Bluffton Okatie Surgery Center, L.L.C.	SC	Ambulatory Surgical Clinic/Center	$1.2M	$0
David Hunter	SC	Ophthalmology Physician	$549.8K	$0
Jeffery Reuben	SC	Specialist	$412.8K	$0
Mikhail Novikov	SC	Nephrology Physician	$391K	$0
Karl Boatright	SC	Orthopaedic Surgery Physician	$349.4K	$0
William Kyle	SC	Internal Medicine Physician	$327.3K	$0
Lauren Lee	SC	Orthopedic Physical Therapist	$246K	$0
Jordan Hickey	SC	Physical Therapist	$229.3K	$0
Elizabeth Liggett	SC	Adult Health Nurse Practitioner	$213.6K	$120

Lindsay Gamble — Billing Profile & Reimbursement Data

Sign up for Lindsay Gamble — Billing Profile & Reimbursement Data policy alerts

Lindsay Gamble — Billing Profile & Reimbursement Data

Sign up for Lindsay Gamble — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References